Compared with a contemporary zotarolimus drug-eluting stent, a coronary bioadaptor system is noninferior among patients with CAD receiving PCI.

A study was conducted to determine the prognostic impact of neutrophil-to-lymphocyte ratio in patients receiving PCI who do and do not have diabetes.

In an attempt to reduce ischemic events during and after percutaneous coronary intervention (PCI), an intensive antiplatelet and anticoagulant regimen has been adopted. The trade-off of this ...

AVVIGO is an intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system designed to provide high-quality IVUS ...

In patients with cardiac arrest, pre-PCI level of consciousness is associated with in-hospital outcomes following PCI.

Supira Medical began patient enrollment in a U.S. early feasibility trial of its percutaneous ventricular assist device (pVAD ...

Patients who suffer a GI bleed after PCI are a challenging group. They may have multiple comorbidities and are often medically unstable; treatment must balance the need to prevent ischemic post ...

TCT 787: Outcomes of Mechanical Circulatory Support Device Use in Female Patients With Cardiogenic Shock (CS) Undergoing Percutaneous Coronary Interventions (PCIs) Receive the the latest news, ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Although percutaneous coronary intervention (PCI) can be performed successfully in most lesions, several difficult lesion subsets continue to present unique technical challenges. These complex ...